Savara, Inc. (SVRA)
5.485
-0.14
(-2.40%)
USD |
NASDAQ |
Mar 05, 16:00
5.485
0.00 (0.00%)
After-Hours: 20:00
Savara Free Cash Flow : -99.27M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ADMA Biologics, Inc. | 27.50M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
| Imunon, Inc. | -14.95M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.53M |
| Cash from Investing (Quarterly) | 21.47M |
| Cash from Financing (Quarterly) | -0.023M |
| Free Cash Flow Per Share (Quarterly) | -0.1041 |
| Free Cash Flow to Equity (Quarterly) | -22.62M |
| Free Cash Flow to Firm (Quarterly) | -22.53M |
| Free Cash Flow Yield | -8.37% |